LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 7.06 | 27.76 | 861 | 360 | 2.3917 | 1.5320 | MN20160318_Q01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 8.76 | 27.76 | 8 | 401 | 0.0199 | -0.2759 | MN20160318_Q01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 8.76 | 27.76 | 756 | 401 | 1.8846 | 1.3575 | MN20160318_Q01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 8.76 | 27.76 | 3 | 401 | 0.0075 | -0.4387 | MN20160318_Q01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 8.76 | 27.76 | 801 | 401 | 1.9968 | 1.3932 | MN20160318_Q01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 8.76 | 27.76 | 8 | 401 | 0.0199 | -0.2759 | MN20160318_Q01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 8.76 | 27.76 | 927 | 401 | 2.3109 | 1.4857 | MN20160318_Q01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 10.46 | 27.76 | 9 | 438 | 0.0205 | -0.2464 | MN20160318_Q01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 10.46 | 27.76 | 843 | 438 | 1.9218 | 1.3566 | MN20160318_Q01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 10.46 | 27.76 | 24 | 438 | 0.0547 | -0.0359 | MN20160318_Q01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 10.46 | 27.76 | 855 | 438 | 1.9492 | 1.3649 | MN20160318_Q01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 10.46 | 27.76 | 5 | 438 | 0.0114 | -0.3498 | MN20160318_Q01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 10.46 | 27.76 | 972 | 438 | 2.2159 | 1.4424 | MN20160318_Q01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 12.17 | 27.76 | 14 | 489 | 0.0286 | -0.1524 | MN20160318_Q01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 12.17 | 27.76 | 883 | 489 | 1.8055 | 1.3069 | MN20160318_Q01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 12.17 | 27.76 | 60 | 489 | 0.1227 | 0.2047 | MN20160318_Q01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 12.17 | 27.76 | 892 | 489 | 1.8239 | 1.3125 | MN20160318_Q01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 12.17 | 27.76 | 7 | 489 | 0.0143 | -0.2831 | MN20160318_Q01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 12.17 | 27.76 | 1042 | 489 | 2.1306 | 1.4010 | MN20160318_Q01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 13.87 | 27.76 | 15 | 604 | 0.0248 | -0.1293 | MN20160318_Q01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 13.87 | 27.76 | 870 | 604 | 1.4387 | 1.1705 | MN20160318_Q01 | E20 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 13.87 | 27.76 | 467 | 604 | 0.7723 | 0.8870 | MN20160318_Q01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 13.87 | 27.76 | 930 | 604 | 1.5379 | 1.2033 | MN20160318_Q01 | H05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 13.87 | 27.76 | 8 | 604 | 0.0132 | -0.2441 | MN20160318_Q01 | I21 |
| MCF 10A-H2B-mCherry | Trametinib | 0.003 | 13.87 | 27.76 | 1117 | 604 | 1.8472 | 1.2961 | MN20160318_Q01 | I21 |